Downstream utrophin enhancer is required for expression of utrophin in skeletal muscle

Jun Tanihata, Naoki Suzuki, Yuko Miyagoe-Suzuki, Kazuhiko Imaizumi, Shin'ichi Takeda

    Research output: Contribution to journalArticle

    5 Citations (Scopus)

    Abstract

    Background: Duchenne muscular dystrophy is caused by the absence of the muscle cytoskeletal protein dystrophin. Utrophin is an autosomal homologue of dystrophin, and overexpression of utrophin is expected to compensate for the dystrophin deficit. We previously reported that the 5.4-kb 5′-flanking region of the utrophin gene containing the A-utrophin core promoter did not drive transgene expression in heart and skeletal muscle. To clarify the regulatory mechanism of utrophin expression, we generated a nuclear localization signal-tagged LacZ transgenic (Tg) mouse, in which the LacZ gene was driven by the 129-bp downstream utrophin enhancer (DUE) and the 5.4-kb 5′-flanking region of the utrophin promoter. Methods: Two Tg lines were established. The levels of transgene mRNA expression in several tissues were examined by reverse transcriptase-polymerase chain reaction (RT-PCR) and quantitative RT-PCR. Cryosections of several tissues were stained with haematoxylin and eosin and X-gal. Results: The transgene expression patterns were consistent with endogenous utrophin in several tissues including heart and skeletal muscle. Transgene expression was also up-regulated more in regenerating muscle than in nonregenerating muscle. Moreover, utrophin expression was augmented in the skeletal muscle of DUE Tg/dystrophin-deficient mdx mice through cross-breeding experiments. We finally established cultures of primary myogenic cells from this Tg mouse and found that utrophin up-regulation during muscle differentiation depends on the DUE motif. Conclusions: Our results showed that DUE is indispensable for utrophin expression in skeletal muscle and heart, and primary myogenic cells from this Tg mice provide a high through-put screening system for drugs that up-regulate utrophin expression.

    Original languageEnglish
    Pages (from-to)702-713
    Number of pages12
    JournalJournal of Gene Medicine
    Volume10
    Issue number6
    DOIs
    Publication statusPublished - 2008 Jun

    Fingerprint

    Utrophin
    Skeletal Muscle
    Dystrophin
    Transgenes
    Transgenic Mice
    5' Flanking Region
    Reverse Transcriptase Polymerase Chain Reaction
    Muscles
    Myocardium
    Up-Regulation
    Inbred mdx Mouse
    Nuclear Localization Signals
    Preclinical Drug Evaluations
    Lac Operon
    Cytoskeletal Proteins
    Primary Cell Culture
    Duchenne Muscular Dystrophy
    Muscle Proteins

    Keywords

    • Downstream utrophin enhancer
    • Duchenne muscular dystrophy
    • Dystrophin
    • Transcriptional regulation
    • Transgenic mice
    • Utrophin

    ASJC Scopus subject areas

    • Genetics

    Cite this

    Tanihata, J., Suzuki, N., Miyagoe-Suzuki, Y., Imaizumi, K., & Takeda, S. (2008). Downstream utrophin enhancer is required for expression of utrophin in skeletal muscle. Journal of Gene Medicine, 10(6), 702-713. https://doi.org/10.1002/jgm.1190

    Downstream utrophin enhancer is required for expression of utrophin in skeletal muscle. / Tanihata, Jun; Suzuki, Naoki; Miyagoe-Suzuki, Yuko; Imaizumi, Kazuhiko; Takeda, Shin'ichi.

    In: Journal of Gene Medicine, Vol. 10, No. 6, 06.2008, p. 702-713.

    Research output: Contribution to journalArticle

    Tanihata, J, Suzuki, N, Miyagoe-Suzuki, Y, Imaizumi, K & Takeda, S 2008, 'Downstream utrophin enhancer is required for expression of utrophin in skeletal muscle', Journal of Gene Medicine, vol. 10, no. 6, pp. 702-713. https://doi.org/10.1002/jgm.1190
    Tanihata, Jun ; Suzuki, Naoki ; Miyagoe-Suzuki, Yuko ; Imaizumi, Kazuhiko ; Takeda, Shin'ichi. / Downstream utrophin enhancer is required for expression of utrophin in skeletal muscle. In: Journal of Gene Medicine. 2008 ; Vol. 10, No. 6. pp. 702-713.
    @article{fa09f386ccc64acebda297d2ae20bd09,
    title = "Downstream utrophin enhancer is required for expression of utrophin in skeletal muscle",
    abstract = "Background: Duchenne muscular dystrophy is caused by the absence of the muscle cytoskeletal protein dystrophin. Utrophin is an autosomal homologue of dystrophin, and overexpression of utrophin is expected to compensate for the dystrophin deficit. We previously reported that the 5.4-kb 5′-flanking region of the utrophin gene containing the A-utrophin core promoter did not drive transgene expression in heart and skeletal muscle. To clarify the regulatory mechanism of utrophin expression, we generated a nuclear localization signal-tagged LacZ transgenic (Tg) mouse, in which the LacZ gene was driven by the 129-bp downstream utrophin enhancer (DUE) and the 5.4-kb 5′-flanking region of the utrophin promoter. Methods: Two Tg lines were established. The levels of transgene mRNA expression in several tissues were examined by reverse transcriptase-polymerase chain reaction (RT-PCR) and quantitative RT-PCR. Cryosections of several tissues were stained with haematoxylin and eosin and X-gal. Results: The transgene expression patterns were consistent with endogenous utrophin in several tissues including heart and skeletal muscle. Transgene expression was also up-regulated more in regenerating muscle than in nonregenerating muscle. Moreover, utrophin expression was augmented in the skeletal muscle of DUE Tg/dystrophin-deficient mdx mice through cross-breeding experiments. We finally established cultures of primary myogenic cells from this Tg mouse and found that utrophin up-regulation during muscle differentiation depends on the DUE motif. Conclusions: Our results showed that DUE is indispensable for utrophin expression in skeletal muscle and heart, and primary myogenic cells from this Tg mice provide a high through-put screening system for drugs that up-regulate utrophin expression.",
    keywords = "Downstream utrophin enhancer, Duchenne muscular dystrophy, Dystrophin, Transcriptional regulation, Transgenic mice, Utrophin",
    author = "Jun Tanihata and Naoki Suzuki and Yuko Miyagoe-Suzuki and Kazuhiko Imaizumi and Shin'ichi Takeda",
    year = "2008",
    month = "6",
    doi = "10.1002/jgm.1190",
    language = "English",
    volume = "10",
    pages = "702--713",
    journal = "Journal of Gene Medicine",
    issn = "1099-498X",
    publisher = "John Wiley and Sons Ltd",
    number = "6",

    }

    TY - JOUR

    T1 - Downstream utrophin enhancer is required for expression of utrophin in skeletal muscle

    AU - Tanihata, Jun

    AU - Suzuki, Naoki

    AU - Miyagoe-Suzuki, Yuko

    AU - Imaizumi, Kazuhiko

    AU - Takeda, Shin'ichi

    PY - 2008/6

    Y1 - 2008/6

    N2 - Background: Duchenne muscular dystrophy is caused by the absence of the muscle cytoskeletal protein dystrophin. Utrophin is an autosomal homologue of dystrophin, and overexpression of utrophin is expected to compensate for the dystrophin deficit. We previously reported that the 5.4-kb 5′-flanking region of the utrophin gene containing the A-utrophin core promoter did not drive transgene expression in heart and skeletal muscle. To clarify the regulatory mechanism of utrophin expression, we generated a nuclear localization signal-tagged LacZ transgenic (Tg) mouse, in which the LacZ gene was driven by the 129-bp downstream utrophin enhancer (DUE) and the 5.4-kb 5′-flanking region of the utrophin promoter. Methods: Two Tg lines were established. The levels of transgene mRNA expression in several tissues were examined by reverse transcriptase-polymerase chain reaction (RT-PCR) and quantitative RT-PCR. Cryosections of several tissues were stained with haematoxylin and eosin and X-gal. Results: The transgene expression patterns were consistent with endogenous utrophin in several tissues including heart and skeletal muscle. Transgene expression was also up-regulated more in regenerating muscle than in nonregenerating muscle. Moreover, utrophin expression was augmented in the skeletal muscle of DUE Tg/dystrophin-deficient mdx mice through cross-breeding experiments. We finally established cultures of primary myogenic cells from this Tg mouse and found that utrophin up-regulation during muscle differentiation depends on the DUE motif. Conclusions: Our results showed that DUE is indispensable for utrophin expression in skeletal muscle and heart, and primary myogenic cells from this Tg mice provide a high through-put screening system for drugs that up-regulate utrophin expression.

    AB - Background: Duchenne muscular dystrophy is caused by the absence of the muscle cytoskeletal protein dystrophin. Utrophin is an autosomal homologue of dystrophin, and overexpression of utrophin is expected to compensate for the dystrophin deficit. We previously reported that the 5.4-kb 5′-flanking region of the utrophin gene containing the A-utrophin core promoter did not drive transgene expression in heart and skeletal muscle. To clarify the regulatory mechanism of utrophin expression, we generated a nuclear localization signal-tagged LacZ transgenic (Tg) mouse, in which the LacZ gene was driven by the 129-bp downstream utrophin enhancer (DUE) and the 5.4-kb 5′-flanking region of the utrophin promoter. Methods: Two Tg lines were established. The levels of transgene mRNA expression in several tissues were examined by reverse transcriptase-polymerase chain reaction (RT-PCR) and quantitative RT-PCR. Cryosections of several tissues were stained with haematoxylin and eosin and X-gal. Results: The transgene expression patterns were consistent with endogenous utrophin in several tissues including heart and skeletal muscle. Transgene expression was also up-regulated more in regenerating muscle than in nonregenerating muscle. Moreover, utrophin expression was augmented in the skeletal muscle of DUE Tg/dystrophin-deficient mdx mice through cross-breeding experiments. We finally established cultures of primary myogenic cells from this Tg mouse and found that utrophin up-regulation during muscle differentiation depends on the DUE motif. Conclusions: Our results showed that DUE is indispensable for utrophin expression in skeletal muscle and heart, and primary myogenic cells from this Tg mice provide a high through-put screening system for drugs that up-regulate utrophin expression.

    KW - Downstream utrophin enhancer

    KW - Duchenne muscular dystrophy

    KW - Dystrophin

    KW - Transcriptional regulation

    KW - Transgenic mice

    KW - Utrophin

    UR - http://www.scopus.com/inward/record.url?scp=46649103864&partnerID=8YFLogxK

    UR - http://www.scopus.com/inward/citedby.url?scp=46649103864&partnerID=8YFLogxK

    U2 - 10.1002/jgm.1190

    DO - 10.1002/jgm.1190

    M3 - Article

    C2 - 18338831

    AN - SCOPUS:46649103864

    VL - 10

    SP - 702

    EP - 713

    JO - Journal of Gene Medicine

    JF - Journal of Gene Medicine

    SN - 1099-498X

    IS - 6

    ER -